InvestorsHub Logo
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

Re: None

Thursday, 10/30/2014 4:33:15 PM

Thursday, October 30, 2014 4:33:15 PM

Post# of 648882
AEGR
Aegerion Pharmaceuticals misses by $0.06, misses on revenue

Aegerion Pharmaceuticals (NASDAQ:AEGR): Q3 EPS of -$0.20 misses by $0.06.
Revenue of $43.67M (+167.4% Y/Y) misses by $4.97M.
Shares -32.91%.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.